Dementia Moderate
15
1
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (15)
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Pain With Dementia
Cognitive Stimulation in Daily Activities for People Living With Early to Middle Stage Dementia
Dronabinol for Agitation in Dementia Crossover Trial
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
An Innovative Supportive Care Model for Dementia and Traumatic Brain Injury
Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions
Chocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged People
Effect of the Group-based Paro Intervention on Physiological and Psychological Outcomes
Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study
Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK)
Advanced Cognitive Stimulation Therapy (ACST)